CERo Therapeutics Holdings Inc. [NASDAQ: CERO] gained 6.14% on the last trading session, reaching $0.26 price per share at the time.
If compared to the average trading volume of 3.96M shares, CERO reached a trading volume of 10559071 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Trading performance analysis for CERO stock
CERo Therapeutics Holdings Inc. [CERO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.00. With this latest performance, CERO shares dropped by -10.61% in over the last four-week period, additionally sinking by -97.69% over the last 6 months – not to mention a drop of -97.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CERO stock in for the last two-week period is set at 39.53, with the RSI for the last a single of trading hit 53.40, and the three-weeks RSI is set at 33.60 for CERo Therapeutics Holdings Inc. [CERO]. The present Moving Average for the last 50 days of trading for this stock 0.5273, while it was recorded at 0.2208 for the last single week of trading, and 5.4571 for the last 200 days.
CERo Therapeutics Holdings Inc. [CERO]: A deeper dive into fundamental analysis
CERo Therapeutics Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.47 and a Current Ratio set at 0.47.
An analysis of Institutional ownership at CERo Therapeutics Holdings Inc. [CERO]
The top three institutional holders of CERO stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in CERO stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in CERO stock with ownership which is approximately 5.1238%.
